Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

Wyeth is now a wholly owned subsidiary of Pfizer32 enrolled

Overview

Safety, tolerability, and pharmacokinetics (PK) of desvenlafaxine succinate sustained release (DVS SR) in healthy Japanese female subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Sex: FEMALEMin age: 20 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy, first-generation (born in Japan, living in the US for less than 5 years) * Japanese female subjects

Safety, Tolerability, PK

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.